Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.

ABSTRACT:

Background

The WHO Essential Medicines List (EML) identifies priority medicines that are most important to public health. Over time, the EML has included an increasing number of cancer medicines. We aimed to investigate whether the cancer medicines in the EML are aligned with the priority medicines of frontline oncologists worldwide, and the extent to which these medicines are accessible in routine clinical practice.

Methods

This international, cross-sectional survey was developed by investigators from a range of clinical practice settings across low-income to high-income countries, including members of the WHO Essential Medicines Cancer Working Group. A 28-question electronic survey was developed and disseminated to a global network of oncologists in 89 countries and region

SUBMITTER: Fundytus A 

PROVIDER: S-EPMC8476341 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature